期刊文献+

肝细胞生长因子与视网膜新生血管形成 被引量:1

下载PDF
导出
摘要 视网膜新生血管形成可造成眼部多种组织成分的广泛损害,已成为世界范围的致盲性疾病。其发生及发展过程复杂,需要多种因素参与,包括多种生长因子的相互作用等。肝细胞生长因子(HGF)作为多效性生长因子,对新生血管形成的作用逐渐被认识。本文主要探讨HGF在视网膜新生血管发病机制中的作用以及与血管内皮生长因子(VEGF)的关系。
作者 陈虹 刘磊
出处 《国外医学(眼科学分册)》 2005年第5期300-303,共4页 Foreign Medical Sciences(Section of Ophthalmology )
  • 相关文献

参考文献28

  • 1Ferrara N, Davis-Smyth T. The biology of vascular endothelial factor. Endocr Res, 1997, 18: 4-25.
  • 2Rosen EM, Lamszus K, Laterra J, et al. HGF/SF in angiogenesis.Ciba Found Symp, 1997,212:215-226.
  • 3Grierson I, Heathcote L, Hiscott P, et al. Hepatocyte growth factor/scatter factor in the eye. Progress in Retinal and Eye Research,2000,19: 779-802.
  • 4Distler JH, Hirth A, Kurowska-Stolarska M, et al. Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q J Nucl Med, 2003, 47: 149-161.
  • 5Sivalingam A, Kenney J, Brown GC, et al. Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol, 1990,108:869-872.
  • 6Heldin CH. Development and possible clinical use of antagonists for PDGF and TGF-beta. Ups J Med Sci, 2004, 109:165-178.
  • 7Lee YM, Bae MH, Lee OH, et al. Synergistic induction of in vivo angiogenesis by the combination of insulin-like growth factor- Ⅱ and epidermal growth factor. Oncol Rep, 2004,12:843-848.
  • 8Grant MB, Afzal A, Spoerri P,et al. The role of growth factors in the pathogenesis of diabetic retinopathy. Expert Opin Investig Drugs. 2004, 13:1275-1293.
  • 9Eichler W, Yafai Y, Wiedemann P, et al. Angiogenesis-related factors derived from retinal glial (Muller) cells in hypoxia. Neuroreport, 2004, 15.1633-1637.
  • 10Komada M, Kitamura N. Regulatory role of major tyrosine autophosphorylation site of kinase domain of c-Met receptor (scatter factor/hepatocyte growth factor receptor). J Biol Chem, 1994,269: 16131-16136.

同被引文献50

  • 1Tse WT, Pendleton JD, Egalka MC, et al. Suppression of allogeneic T- cell proliferation by human marrow stromal ceils: implications in transplantation. Transplantation 2003 ;75 (3) :389-397.
  • 2Corcione A, Benvenuto F, Ferretti E, et al. Human mesenchymal stem cells modulate B-cell functions. Blood 2006 ; 107( 1 ) :367-372.
  • 3Spaggiari GM, Capobianco A, Abdelrazik H, et al. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production:role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 2008;111(3) :1327-1333.
  • 4Asari S, Itakura S, Ferreri K, et al. Mesenchymal stem cells suppress B- cell terminal differentiation. Exp Hematol 2009 ;37 (5) :604-615.
  • 5Jiang XX, Zhang Y, Liu B, et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 2005 ; 105 ( 10 ) :4120-4126.
  • 6Deans R J, Moseley AB. Mesenchymal stem cells:biology and potential clinical uses. Exp Hematol 2000 ;28 ( 8 ) :875-884.
  • 7Li Y,Qu YH, Wu YF, et al. Bone marrow mesenchymal stem cells suppressing activation of allogeneic cytokine-induced killer/natural killer cells either by direct or indirect interaction. Cell Biol Int 2014 ; 39(4) : 435 -445.
  • 8Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007 ; 110(10) :3499-3506.
  • 9Machado CV, Telles PD, Nascimento IL. Immunological characteristics of mesenchymal stem cells. Rev Bras Hematol Hemoter 2013; 35(1) : 62-67.
  • 10Zhang W, Ge W, Li C, et al. Effects of mesenchymal stem cells on differentiation, maturation and function of human monocyte- derived dendritic cells. Stem Cells Dev 2004 ; 13 ( 3 ) :263-271.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部